We are live on ! Find out more
QF

QVT Financial Portfolio holdings

AUM $1.37B
1-Year Est. Return 148.1%
This Fund
S&P 500
This Quarter Est. Return
+12.12%
1 Year Est. Return
+148.1%
3 Year Est. Return
+280.64%
5 Year Est. Return
+413.55%
10 Year Est. Return
+2,213.36%
AUM
$2.65B
AUM Growth
+$1.2B
Cap. Flow
+$657M
Cap. Flow %
24.78%
Top 10 Hldgs %
70.55%
Holding
84
New
9
Increased
8
Reduced
22
Closed
13

Top Buys

Rank Stock Value
1
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
+$1.13B
2
ABUS icon
Arbutus Biopharma
ABUS
+$62.6M
3
CTRA
Coterra Energy
CTRA
+$20.6M
4
AMBA icon
Ambarella
AMBA
+$17.3M
5
PYPL icon
PayPal
PYPL
+$13.2M

Top Sells

Rank Stock Value
1
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
+$53.7M
2
Z icon
Zillow
Z
+$24.1M
3
ZG icon
Zillow
ZG
+$22M
4
GS icon
Goldman Sachs
GS
+$16M
5
CYTR
CytRx Corp
CYTR
+$12.1M

Sector Composition

Rank Sector Weight
1 Healthcare 50.64%
2 Financials 3.83%
3 Technology 2.66%
4 Communication Services 2.22%
5 Energy 1.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMRN icon
26
BioMarin Pharmaceuticals
BMRN
$11.5B
$12.4M 0.47%
133,933
+36,687
+38% +$3.45M
TSM icon
27
PUT
TSMC
TSM
$2.09T
$12.2M 0.46%
400,000
– –
WFC icon
28
Wells Fargo
WFC
$261B
$11.3M 0.43%
255,000
-75,000
-23% -$3.59M
BRFS
29
DELISTED
BRF SA
BRFS
$10.4M 0.39%
607,112
– –
JOYY
30
JOYY Inc
JOYY
$3.73B
$10.2M 0.38%
+190,700
New +$8.71M
AR icon
31
Antero Resources
AR
$10.9B
$10.1M 0.38%
+373,413
New +$9.95M
AVXS
32
DELISTED
AveXis, Inc. Common Stock
AVXS
$9.26M 0.35%
224,756
-18,000
-7% -$684K
TNK icon
33
Teekay Tankers
TNK
$2.63B
$9.25M 0.35%
456,847
– –
XNCR icon
34
Xencor
XNCR
$1.44B
$8.74M 0.33%
356,873
-30,052
-8% -$636K
FIT
35
DELISTED
Fitbit, Inc. Class A common stock
FIT
$8.6M 0.32%
579,502
– –
EPZM
36
DELISTED
Epizyme, Inc
EPZM
$8.37M 0.32%
850,446
-121,500
-13% -$1.11M
SCTY
37
DELISTED
SolarCity Corporation
SCTY
$7.96M 0.3%
406,816
– –
SCTY
38
PUT
DELISTED
SolarCity Corporation
SCTY
$7.94M 0.3%
406,000
– –
BLCM
39
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$7.74M 0.29%
38,884
-11,910
-23% -$2.05M
JPM icon
40
JPMorgan Chase
JPM
$939B
$7.33M 0.28%
110,000
-70,000
-39% -$4.56M
ZX
41
DELISTED
China Zenix Auto Internatl Ltd
ZX
$5.81M 0.22%
6,074,805
– –
ONC
42
BeOne Medicines Ltd
ONC
$33.8B
$5.24M 0.2%
170,000
– –
RGNX icon
43
Regenxbio
RGNX
$623M
$5.2M 0.2%
370,943
-53,425
-13% -$590K
ADAP
44
DELISTED
Adaptimmune Therapeutics
ADAP
$5.09M 0.19%
722,233
-61,412
-8% -$468K
ASMB icon
45
Assembly Biosciences
ASMB
$506M
$5.06M 0.19%
67,300
– –
IMAX icon
46
IMAX
IMAX
$2.38B
$4.91M 0.19%
+169,400
New +$5.16M
NAT icon
47
Nordic American Tanker
NAT
$1.37B
$4.86M 0.18%
484,969
-655,200
-57% -$7.61M
BLUE
48
DELISTED
bluebird bio
BLUE
$4M 0.15%
4,555
– –
FRO icon
49
Frontline
FRO
$8.75B
$2.93M 0.11%
408,341
– –
OCRX
50
DELISTED
Ocera Therapeutics, Inc.
OCRX
$2.33M 0.09%
932,086
– –
1
2
3

Similar funds

KRS
Kentucky Retirement Systems Frankfort, Kentucky $1.37B AUM 33.36% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
DC
Dendur Capital New York $1.36B AUM 38.43% 1-Year Est. Return
FC
FORA Capital Miami, Florida $1.36B AUM 56.1% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.37B AUM 19.97% 1-Year Est. Return
SOS
Silver Oak Securities Jackson, Tennessee $1.37B AUM 20.67% 1-Year Est. Return

QVT Financial's Q3 2016 Portfolio in Review

As of Q3 2016, QVT Financial held 84 positions worth $2.65B, up 83% from $1.45B the previous quarter. Its ten largest holdings account for 71% of the portfolio.

QVT Financial deployed $657M of net new capital in Q3 2016, opening 9 new positions and adding to 8 existing holdings. Its largest new stake was Sio Gene Therapies Inc. Common Stock: 9,375,000 shares worth $1.05B.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Goldman Sachs, an estimated $16M trimmed.

  • QVT Financial's largest Q3 2016 buy was Sio Gene Therapies Inc. Common Stock: 9,375,000 shares worth $1.05B.
  • QVT Financial added most to iShares Biotechnology ETF in Q3 2016, an estimated $9.58M increase.
  • QVT Financial's biggest Q3 2016 reduction was Goldman Sachs, cutting an estimated $16M.
  • QVT Financial fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $53.7M.
  • QVT Financial's ten largest holdings make up 71% of its $2.65B portfolio in Q3 2016.
  • QVT Financial opened 9 new positions and closed 13 in Q3 2016.
  • QVT Financial's portfolio value rose 83% quarter-over-quarter to $2.65B.

Based on QVT Financial's 13F filing for Q3 2016, filed 14 Nov 2016.